What is the role of intra-aortic balloon pump therapy in patients with acute-on-chronic heart failure and cardiogenic shock?

2018 ◽  
Vol 37 (11) ◽  
pp. 1301-1303
Author(s):  
Jerry D. Estep
2021 ◽  
Vol 23 (Supplement_C) ◽  
pp. C204-C220
Author(s):  
Roberta Rossini ◽  
Serafina Valente ◽  
Furio Colivicchi ◽  
Cesare Baldi ◽  
Pasquale Caldarola ◽  
...  

Abstract The treatment of patients with advanced acute heart failure is still challenging. Intra-aortic balloon pump (IABP) has widely been used in the management of patients with cardiogenic shock. However, according to international guidelines, its routinary use in patients with cardiogenic shock is not recommended. This recommendation is derived from the results of the IABP-SHOCK II trial, which demonstrated that IABP does not reduce all-cause mortality in patients with acute myocardial infarction and cardiogenic shock. The present position paper, released by the Italian Association of Hospital Cardiologists, reviews the available data derived from clinical studies. It also provides practical recommendations for the optimal use of IABP in the treatment of cardiogenic shock and advanced acute heart failure.


2014 ◽  
Vol 38 (11) ◽  
pp. 967-972 ◽  
Author(s):  
Yalin Yildirim ◽  
Simon Pecha ◽  
Mathias Kubik ◽  
Yousuf Alassar ◽  
Tobias Deuse ◽  
...  

Author(s):  
Nuccia Morici ◽  
Claudia Marini ◽  
Alice Sacco ◽  
Guido Tavazzi ◽  
Francesco Saia ◽  
...  

2007 ◽  
Vol 6 (1) ◽  
pp. 174-175
Author(s):  
O KHALEVA ◽  
N NIKITIN ◽  
A CLARK ◽  
K GOOD ◽  
A RIGBY ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document